Procter & Gamble Health Share Price
5660.00-97.50 (-1.69%)
-10.39% past 1 Year
Procter & Gamble Health Limited (formerly Merck Limited) was set up in India as one of Merck’s Asian subsidiaries in 1967. It was also the first Merck Group Company to
Corporate filings & documents
Announcements
Enclosed a summary of proceedings of the Annual General Meeting held today viz. September 3 2026.
21 hours agoEnclosed a summary of proceedings of the Annual General Meeting held today viz. September 3 2026.
21 hours agoThe 59th Annual General Meeting of the Company is scheduled on Thursday September 3 2026 at 2:30 PM.
3 weeks agoThe 59th Annual General Meeting of the Company is scheduled on Thursday September 3 2026 at 2:30 PM.
3 weeks agoThe BRSR Report for the Financial Year ended March 31 2026 is enclosed.
3 weeks agoThe BRSR Report for the Financial Year ended March 31 2026 is enclosed.
3 weeks agoAnnual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3 2026.
3 weeks agoAnnual Report for the Financial Year 2025-26 is enclosed for the Annual General Meeting scheduled on Thursday September 3 2026.
3 weeks agoEnclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company scheduled on Thursday September 3 2026 at 2:30 p.m.
3 weeks agoEnclosed herewith is the Annual Report for the Financial Year 2025-26 and Notice calling the 59th Annual General Meeting of the Company scheduled on Thursday September 3 2026 at 2:30 p.m.
3 weeks agoRecord Date for Purpose of Dividend
3 weeks agoRecord Date for Purpose of Dividend
3 weeks agoPress Release on the Unaudited Financial Results for the Quarter ended June 30 2026.
4 weeks agoPress Release on the Unaudited Financial Results for the Quarter ended June 30 2026.
4 weeks agoUnaudited Financial Results for the Quarter ended June 30 2026
4 weeks agoUnaudited Financial Results for the Quarter ended June 30 2026
4 weeks agoOutcome of Board Meeting.
4 weeks agoOutcome of Board Meeting.
4 weeks agoDear Sir/Madam Please find attached intimation regarding change in Companys Annual General Meeting date for the Financial Year 2025-26 and record date for purpose of AGM/distribution of final dividend.
1 month agoDear Sir/Madam Please find attached intimation regarding change in Companys Annual General Meeting date for the Financial Year 2025-26 and record date for purpose of AGM/distribution of final dividend.
1 month agoDear Sir Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations for the quarter ended June 30 2026.
2 months agoDear Sir Please find attached signed certificate for confirming compliance under Regulation 74 (5) of the SEBI (DP) Regulations for the quarter ended June 30 2026.
2 months agoDear Sir Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company if approved by the shareholders at the ensuing AGM.
2 months agoDear Sir Please find attached communication in respect of deduction of TDS on the amount of final dividend income from the Company if approved by the shareholders at the ensuing AGM.
2 months agoDear Sir Please find attached our intimation for closure of trading window.
2 months agoDear Sir Please find attached our intimation for closure of trading window.
2 months agoProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Dear Sir In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday August 6 2026 inter alia to consider and approve unaudited Financial Results for the quarter ended June 30 2026. Kindly take the same on record.
2 months agoProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Dear Sir In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday August 6 2026 inter alia to consider and approve unaudited Financial Results for the quarter ended June 30 2026. Kindly take the same on record.
2 months agoPursuant to regulation 30 of the SEBI (LODR) Regulations 2015 we hereby inform you regarding changes in the Senior Management Personnel of the Company shall take place effective July 1 2026.
2 months agoPursuant to regulation 30 of the SEBI (LODR) Regulations 2015 we hereby inform you regarding changes in the Senior Management Personnel of the Company shall take place effective July 1 2026.
2 months agoThe Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.
2 months agoThe Company has informed the Stock Exchange regarding the transcript and link to the recording of the analyst/institutional investors meeting held earlier today.
2 months agoThe Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.
2 months agoThe Company has informed the Stock Exchange regarding the Presentation of the Analyst/Institutional investor meet scheduled to be held today.
2 months agoWe wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8 2026. The company will share meeting link and details to the participants who have registered separately.
3 months agoWe wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 18th at 2.30 pm IST. Institutional investors/Analysts interested in joining the connect are requested to complete the registration on link provided in the attached intimation by June 8 2026. The company will share meeting link and details to the participants who have registered separately.
3 months agoPlease find attached signed Annual Secretarial Compliance report for the year ended March 31 2026
3 months agoRecord date for purpose of dividend
3 months agoRecord date for purpose of dividend
3 months agoBoard has recommended final dividend for the Financial Year 2025-26 subject to approval of shareholders.
3 months agoPlease find attached press release for the quarter and financial year ended March 31 2026.
3 months agoDear Sir Please find attached intimation for re appointment of Independent Director.
3 months agoDear Sir Please find attached audited financial results for the year ended March 31 2026.
3 months agoWe are enclosing herewith the following:a. Audited Financial Results for the Financial Year ended March 31 2026 as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015;b. Auditors Report in respect of the aforementioned Financial Results as furnished by the Statutory Auditors of the Company;c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial ResultsWe are pleased to further inform you that the Board of Directors of the Company at its meeting held today inter alia have recommended a dividend of Rs. 45 per Equity Share (Nominal Value of Rs. 10/- each) for the Financial Year ended March 31 2026. The divided shall be paid on or before September 25 2026 on approval of the Members at the ensuing Annual General Meeting.
3 months agoWe are enclosing herewith the following:a. Audited Financial Results for the Financial Year ended March 31 2026 as per format prescribed under Regulation 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015;b. Auditors Report in respect of the aforementioned Financial Results as furnished by the Statutory Auditors of the Company;c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial ResultsWe are pleased to further inform you that the Board of Directors of the Company at its meeting held today inter alia have recommended a dividend of Rs. 45 per Equity Share (Nominal Value of Rs. 10/- each) for the Financial Year ended March 31 2026. The divided shall be paid on or before September 25 2026 on approval of the Members at the ensuing Annual General Meeting.
3 months agoDear Sir Please find attached our intimation under Regulation 30 of the SEBI (LODR) Regulations 2015. Request you to kindly take the same on record.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Procter & Gamble Health Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1967PLC013726</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: ZEAL RUPANI <br/> Designation: Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SHASHANK SROWTHY <br/> Designation: CFO Director <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 06/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
5 months agoDear Sir/Madam Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations for the quarter ended March 31 2026.
5 months agoDear Sir/Madam Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations for the quarter ended March 31 2026.
5 months agoProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on May 26 2026
5 months agoAnnual reports
Concalls & investor presentations
Nov 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-08-27
Dividend
45.0
2026-02-12
Dividend
110.0
2026-02-12
Dividend
50.0
2025-08-22
Dividend
45.0
2025-02-21
Dividend
80.0
2024-11-28
Dividend
60.0
2024-02-14
Dividend
50.0
2023-11-23
Dividend
50.0
2023-11-13
Dividend
50.0
2023-02-13
Dividend
45.0
2022-11-15
Dividend
11.5
2022-05-12
Dividend
41.0
2021-11-02
Dividend
130.0
2020-11-18
Dividend
230.0
Company details
Registered office
Ground Floor And First Floor P & G Plaza Cardinal Gracias Road Chakala, Andheri (East) Mumbai Maharashtra PIN: 400099 Tel No: 022 68669000 Fax No: 022 25186828 Email: [email protected] Internet: www.pghealthindia.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Zeal Rupani, Company Secretary & Compliance Officer
S Madhavan, Chairman
Aalok Agrawal, Non Executive Director
Seema Sambasivan, Non Executive Director
Krishna Sarma, Non Executive Independent Director
Sharad Tyagi, Non Executive Independent Director
Shashank Srowthy, Executive Director & Chief Financial Officer
Milind Thatte, Managing Director
Details
BSE 500126
NSE PGHL
ISIN INE199A01012